Navigation Links
Cells selectively absorb short nanotubes

DNA-wrapped single-walled carbon nanotubes (SWCNTs) shorter than about 200 nanometers readily enter into human lung cells and so may pose an increased risk to health, according to scientists at the National Institute of Standards and Technology (NIST). The results of their laboratory studies appear in an upcoming issue of Advanced Materials.*

Eyed for uses ranging from electronic displays to fuel cells to water filtration, SWCNTs are tiny cylinders—essentially single-sheet rolls of carbon atoms. They are many times stronger than steel and possess superlative thermal, optical and electronic properties, but safety and biocompatibility remain an open question.

"Published data citing in vitro (outside the body) toxicity are particularly inconsistent and widely disputed," writes biomaterials scientist Matthew Becker and his NIST colleagues. Public concerns surrounding the environmental, health and safety impacts of SWCNTs could derail efforts to fast track the development of nanotubes for advanced technology applications. A significant hurdle in outlining the parameters contributing to nanotube toxicity is to prepare well-defined and characterized nanotube samples, as they typically contain a distribution of lengths, diameters, twists and impurities.

The team chose to isolate the effects of nanotube length. They first adsorbed short DNA molecules onto the nanotubes because this renders them soluble in water and allows them to be sorted and separated by length. The researchers then exposed human lung fibroblasts to solutions containing unsorted nanotubes. Regardless of the concentration levels, the cells did not absorb between about one-fourth and one-third of the SWCNTs in the solutions. Further examination of the results revealed that only short nanotubes made it into the cellular interior.

In the next phase of the research, the team exposed the cells to sorted nanotubes of controlled length. They found that tubes longer than abou t 200 nanometers were excluded from the cells and remained in solution. Cells exposed to the longer nanotube solutions did not undergo a decrease in metabolic activity, but cells exposed to nanotubes below that threshold absorbed them and, depending on the concentration level, died or showed other signs of toxicity. "Our results demonstrate that cellular uptake in these lung cells depends significantly on the length of the nanotubes," Becker explains. "This is the first of many steps in the critical goal of reducing health risk by de novo engineering of the nanotubes themselves."
'"/>

Source:National Institute of Standards and Technology (NIST)


Related biology news :

1. Jump-starting T Cells In Skin Cancer
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates
4. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
5. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
6. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
7. Placenta Is A Rich Source Of Blood Stem Cells
8. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
9. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
10. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
11. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
(Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
(Date:3/22/2017)... Mass. , March 22, 2017   Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ...
Breaking Biology Technology: